NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Nexentis Technologies Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.64−0.00 (-0.73%)
Close on Oct 19, 2026
- Market cap
- $522.65K
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
4.4%
0M of 1M shares
Institutional holders
6
5 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 1 sales
Net sold $173
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Gleb Fetisov | 86,027 | 5.90% | 13G (passive) | Nov 14, 2023 |
| SciSparc Ltd. | 490,751 | 18.30% | 13G (passive) | Oct 20, 2025 |
| Alon Silberman | 454,127 | 16.93% | 13G (passive) | Oct 20, 2025 |
| Kfir Silberman | 2,064,286 | 7.81% | 13G (passive) amendment | May 15, 2025 |
| Amir Uziel | 1,376,786 | 5.35% | 13G (passive) amendment | May 15, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NXTS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Hrt Financial LP | 45,240 | 3.11% | $194 | New | 0.00% |
| Yorkville Advisors Global, LP | 16,409 | 1.13% | $70.72K | New | 0.08% |
| Vanguard Fiduciary Trust Co | 998 | 0.07% | $4.30K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 736 | 0.05% | $3.17K | New | 0.00% |
| SBI Securities Co., Ltd. | 32 | 0.00% | $138 | −26 | 0.00% |
| Barclays PLC | 1 | 0.00% | $4 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 6 | 0M | 4.4% | 5 / 0 | 1 / 0 | 0M | 0M |
| Q1 2026 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of NXTS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 6,978 | 0.48% | $38.45K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 97 | 0.01% | $534 | 0.00% | May 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 2 | 0.00% | $9 | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Shlomo Zakai | Controller | 87,000 | 5.99% | Feb 11, 2026 |
| Lital Barda | Chief Financial Officer | 267,227 | 18.39% | Feb 11, 2026 |
| David Palach | Chief Executive Officer | 549,144 | 37.79% | Feb 11, 2026 |
| Amitay Weiss | Director | 579,144 | 39.85% | Feb 11, 2026 |
| Udi Ovadia Kalifi | Director | 68,457 | 4.71% | Dec 26, 2024 |
| Asaf Itzhaik | Director | 50,000 | 3.44% | Dec 26, 2024 |
| Eliahou Arbib | Director | 64,500 | 4.44% | Dec 26, 2024 |
| Liat Sidi | Director | 50,000 | 3.44% | Dec 26, 2024 |
| Ronen Rosenbloom | Director | 64,500 | 4.44% | Dec 26, 2024 |
| Israel Yakov Berenstein | Director | 64,500 | 4.44% | Dec 26, 2024 |
| Eun Young Lee | 10% owner | 479,524 | 32.99% | Mar 26, 2026 |
| Alon Silberman | 10% owner | 454,127 | 31.25% | Oct 28, 2025 |
| Ltd. SciSparc | 10% owner | 490,751 | 33.77% | Oct 24, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Amitay Weiss Director | Feb 9, 2026 | Award | +116,286 | – | – | 129,144 |
| Lital Barda Chief Financial Officer | Feb 9, 2026 | Award | +50,000 | – | – | 64,370 |
| David Palach Chief Executive Officer | Feb 9, 2026 | Award | +100,000 | – | – | 129,144 |
| Shlomo Zakai Controller | Feb 9, 2026 | Award | +50,000 | – | – | 64,778 |
| Eun Young Lee 10% owner | Jan 29, 2026 | Sale | −127 | $1.36 | $173 | 479,524 |
| Lital Barda Chief Financial Officer | May 12, 2025 | Award | +300,000 | – | – | 502,857 |
| David Palach Chief Executive Officer | May 12, 2025 | Award | +600,000 | – | – | 1,020,000 |
| Eliahou Arbib Director | Dec 23, 2024 | Award | +50,000 | – | – | 64,500 |
| Ronen Rosenbloom Director | Dec 23, 2024 | Buy | +50,000 | – | – | 64,500 |
| Asaf Itzhaik Director | Dec 23, 2024 | Award | +50,000 | – | – | 50,000 |
| Udi Ovadia Kalifi Director | Dec 23, 2024 | Award | +50,000 | – | – | 68,457 |
| Liat Sidi Director | Dec 23, 2024 | Award | +50,000 | – | – | 50,000 |
| Amitay Weiss Director | Dec 23, 2024 | Award | +350,000 | – | – | 450,000 |
| Israel Yakov Berenstein Director | Dec 23, 2024 | Award | +50,000 | – | – | 64,500 |
| Lital Barda Chief Financial Officer | Sep 12, 2024 | Award | +160,000 | – | – | 202,857 |
| David Palach Chief Executive Officer | Sep 12, 2024 | Award | +320,000 | – | – | 420,000 |
| Israel Yakov Berenstein Director | Dec 20, 2023 | Buy | +14,500 | – | – | 14,500 |
| Amitay Weiss Director | Dec 20, 2023 | Buy | +100,000 | – | – | 100,000 |
| Udi Ovadia Kalifi Director | Dec 20, 2023 | Buy | +14,500 | – | – | 18,457 |
| Eliahou Arbib Director | Dec 20, 2023 | Buy | +14,500 | – | – | 14,500 |
| David Palach Chief Executive Officer | Dec 20, 2023 | Award | +57,142 | – | – | 100,000 |
| Lital Barda Chief Financial Officer | Dec 20, 2023 | Award | +28,571 | – | – | 42,857 |
| Ronen Rosenbloom Director | Dec 20, 2023 | Buy | +14,500 | – | – | 14,500 |
| David Palach Chief Executive Officer | Mar 29, 2023 | Award | +300,000 | – | – | 300,000 |
| Lital Barda Chief Financial Officer | Mar 29, 2023 | Award | +100,000 | – | – | 100,000 |
| Udi Ovadia Kalifi Director | Jun 16, 2022 | Buy | +18,422 | $3.30 | $60.79K | 27,692 |
| Udi Ovadia Kalifi Director | Jun 15, 2022 | Buy | +9,270 | $3.16 | $29.29K | 9,270 |
| Benad Goldwasser Director | Sep 24, 2020 | Option exercise | +68,000 | $0.30 | $20.40K | 400,000 |
| Benad Goldwasser Director | Sep 22, 2020 | Option exercise | +132,000 | $0.30 | $39.60K | 332,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.